Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advancing combination therapy for Alzheimer's disease
Stephen Salloway, Jeff Sevingy, Kumar Budur, et al.
Alzheimer s & Dementia Translational Research & Clinical Interventions (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

The promise of microRNA-based therapies in Alzheimer’s disease: challenges and perspectives
Hannah Walgrave, Lujia Zhou, Bart De Strooper, et al.
Molecular Neurodegeneration (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 91
The informed road map to prevention of Alzheimer Disease: A call to arms
Eric McDade, Jorge J. Llibre‐Guerra, David M. Holtzman, et al.
Molecular Neurodegeneration (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 65
microRNA-132 regulates gene expression programs involved in microglial homeostasis
Hannah Walgrave, Amber Penning, Giorgia Tosoni, et al.
iScience (2023) Vol. 26, Iss. 6, pp. 106829-106829
Open Access | Times Cited: 24
Key considerations for combination therapy in Alzheimer's clinical trials: Perspectives from an expert advisory board convened by the Alzheimer's drug discovery foundation
Jeffrey Cummings, Michael Gold, Mark Mintun, et al.
The Journal of Prevention of Alzheimer s Disease (2025) Vol. 12, Iss. 1, pp. 100001-100001
Open Access | Times Cited: 1
Immune Modulation in Alzheimer’s Disease: From Pathogenesis to Immunotherapy
Sahar Balkhi, Antimo Di Spirito, Alessandro Poggi, et al.
Cells (2025) Vol. 14, Iss. 4, pp. 264-264
Open Access | Times Cited: 1
Brain-neuron targeted nanoparticles for peptide synergy therapy at dual-target of Alzheimer's disease
Qian Guo, Yixian Li, Shuting Xu, et al.
Journal of Controlled Release (2023) Vol. 355, pp. 604-621
Closed Access | Times Cited: 19
Synapses, Microglia, and Lipids in Alzheimer’s Disease
Patrick Jarmo Paasila, Jason Abbas Aramideh, Greg T. Sutherland, et al.
Frontiers in Neuroscience (2022) Vol. 15
Open Access | Times Cited: 25
Inhibition of phosphodiesterase: A novel therapeutic target for the treatment of mild cognitive impairment and Alzheimer’s disease
Jianwen Sheng, Shanjin Zhang, Lule Wu, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 23
Single-cell-led drug repurposing for Alzheimer’s disease
Silvia Parolo, Federica Mariotti, Pranami Bora, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 14
Approaches for Increasing Cerebral Efflux of Amyloid-β in Experimental Systems
David A. Loeffler
Journal of Alzheimer s Disease (2024) Vol. 100, Iss. 2, pp. 379-411
Open Access | Times Cited: 6
BACE1 Inhibitors for Alzheimer’s Disease: Current Challenges and Future Perspectives
Judite R.M. Coimbra, Rosa Resende, José B.A. Custódio, et al.
Journal of Alzheimer s Disease (2024) Vol. 101, Iss. s1, pp. S53-S78
Closed Access | Times Cited: 6
Non-canonical pathways associated to Amyloid beta and tau protein dyshomeostasis in Alzheimer’s disease: A narrative review
Anna Maggiore, Valentina Latina, Maria D’Erme, et al.
Ageing Research Reviews (2024) Vol. 102, pp. 102578-102578
Open Access | Times Cited: 4
Operationalizing selection criteria for clinical trials in Alzheimer's disease: Biomarker and clinical considerations: Proceedings from the Alzheimer's Association Research Roundtable (AARR) Fall 2021 meeting
Ronald C. Petersen, Ana Graf, Chris Brady, et al.
Alzheimer s & Dementia Translational Research & Clinical Interventions (2025) Vol. 11, Iss. 1
Open Access
Carbon Sequestration Potential of Tropical Fruit Trees
S Preetha, S. Sheeba, S. Shenbagavalli, et al.
Communications in Soil Science and Plant Analysis (2025), pp. 1-19
Closed Access
Interplay Between Vascular Dysfunction and Neurodegenerative Pathology: New Insights into Molecular Mechanisms and Management
A Mekala, Hongyu Qiu
Biomolecules (2025) Vol. 15, Iss. 5, pp. 712-712
Open Access
Impact of New Drugs for Therapeutic Intervention in Alzheimer’s Disease
Jordi Olloquequi, Miren Ettcheto, Amanda Cano, et al.
Frontiers in Bioscience-Landmark (2022) Vol. 27, Iss. 5, pp. 146-146
Open Access | Times Cited: 16
Manipulation of the diet–microbiota–brain axis in Alzheimer’s disease
Daniel Lee, Virginia M.‐Y. Lee, Seong Kwon Hur
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 13
An Argument for Simple Tests of Treatment of Alzheimer’s Disease
Timothy Daly, Ignacio Mastroleo, Vincent Henry, et al.
Journal of Alzheimer s Disease (2022) Vol. 86, Iss. 1, pp. 49-52
Open Access | Times Cited: 12
Therapeutic Advances in Diabetes, Autoimmune, and Neurological Diseases
Jinsha Liu, Joey Ting, Shams Al-Azzam, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 6, pp. 2805-2805
Open Access | Times Cited: 15
Combination Therapy in Alzheimer’s Disease: Is It Time?
Arash Salehipour, Motahareh Bagheri, Mohammadmahdi Sabahi, et al.
Journal of Alzheimer s Disease (2022) Vol. 87, Iss. 4, pp. 1433-1449
Open Access | Times Cited: 11
Gut Microbiota and Immunotherapy for Alzheimer’s Disease
Chun‐Ling Dai, Fei Liu, Khalid Iqbal, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 15230-15230
Open Access | Times Cited: 11
Genetic, transcriptomic, histological, and biochemical analysis of progressive supranuclear palsy implicates glial activation and novel risk genes
Kurt Farrell, Jack Humphrey, Timothy S. Chang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 6
Updates on pharmacological treatment for Alzheimer’s disease
Philip W. Tipton
Neurologia i Neurochirurgia Polska (2023) Vol. 58, Iss. 2, pp. 150-160
Open Access | Times Cited: 5
Amyloid-beta Targeted Therapeutic Approaches for Alzheimer’s Disease: Long Road Ahead
Yuxuan Dai, Chenyi Lei, Zhenhao Zhang, et al.
Current Drug Targets (2022) Vol. 23, Iss. 11, pp. 1040-1056
Closed Access | Times Cited: 9
Page 1 - Next Page

Scroll to top